Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma - Wikidata - awgldk - TriplyDB

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

http://www.wikidata.org/entity/Q35241051

about

Toll-like receptor 9 in breast cancer.DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells Tumor infiltrating CD8(+) T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer Whole blood expression profiling from the TREAT trial: insights for the pathogenesis of polyarticular juvenile idiopathic arthritis Biopathological Significance of TLR9 Expression in Cancer Cells and Tumor Microenvironment Across Invasive Breast Carcinomas Subtypes.Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo.Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.Cell membrane and intracellular expression of toll-like receptor 9 (TLR9) in colorectal cancer and breast cancer cell-lines.Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro.Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis.Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis.Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer.Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients.High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients.MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer.Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma.Toll-like receptor-9 in Spanish multiple sclerosis patients: an association with the gender.TLR9 signaling activation at different stages in colorectal cancer and NF-kappaB expression

P2860

Q33928402-40830B06-CF14-432F-8816-05DF1D8A2356 Q34549200-1096BE71-595E-46B4-AA29-7F7D2656B85B Q35798941-70E6246E-CF5A-469B-9CF4-981DEEE7128D Q36066556-3EF68C05-D9EF-42E3-91D9-187CEDE044A0 Q37073220-B8C8D2BD-1876-4A9B-A831-4D7C50D3D7D6 Q37605221-DE006B35-F3DF-4094-A189-7D080AA2C69B Q37699431-5302E8D3-FE92-4706-98AD-29CD178A6A0B Q38039958-6D31AF91-1EFF-4CE1-A672-1020DA7362A2 Q38720388-7557248C-61B6-49ED-BBFA-310A5A8560DB Q38802341-A8EECB67-F613-42C3-8948-9466D627AFEB Q39028490-C51CB0D1-A302-4760-A488-7B5E5937BEDB Q39168823-A26A1B89-4FA9-4E14-A4F6-2C97964B1FFA Q39305431-9E6A3F52-CD12-4130-AC67-22CDDED7558A Q40063898-979EAC87-0349-4B98-85FA-E82E56501B91 Q40338679-7402AAA3-2821-4934-9604-CD1D2E5AEA2E Q41008660-D2ECF311-A0E7-4974-801A-73FD7E174AF5 Q41497232-FED6B435-8428-4CB9-A766-D91B6136FC41 Q42149484-6B5FF11A-5DE9-406A-AB83-B2CF512FFF45 Q42969284-260BD5C1-F70A-45B7-9EFB-0F61C1123196 Q44417361-EA13EC65-6BF4-4BAC-8CD5-370EBD7FB4F1 Q57073978-0CB9565D-4F3E-4EAB-A30A-CE303EB3A942

P2860

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

http://www.wikidata.org/entity/Q35241051

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

@ast

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

@en

type

label

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

@ast

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

@en

prefLabel

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

@ast

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

@en

P1433

Q35241051-B55C1CAC-F1DB-4665-9DC0-F7052FE61347

P1476

Q35241051-F50A7D49-6A96-4236-B5DA-58E91C73E861

P2093

Q35241051-1315150A-3211-4243-864A-2228DB7CA4B5

Q35241051-25E1C021-9AB5-45D2-BFAD-D86C81863D88

Q35241051-29C26AB7-6F7B-4D5F-B714-834E4B5EDCEB

Q35241051-6EFC14D9-3DB8-439A-9C45-312B91D31C42

Q35241051-719C4B23-8BCD-4957-A547-F2204E4AAD48

Q35241051-B221B052-E231-4FC2-86CB-7F6E1CDCB83A

Q35241051-E9066177-F0B0-4A68-9054-AF7571F89DCB

P2860

Q35241051-0200E083-1B57-4F40-A7CE-3E9DE209B6EC

Q35241051-0895FA0D-64BE-444C-AF7A-A53114E8E38B

Q35241051-0CB17812-F90A-4AAA-8235-26D093E3DCD3

Q35241051-0F354DC3-6FF1-4BC7-8818-2C0D6C095F6A

Q35241051-11C94170-CBF1-4AD4-AFD9-0B79EECADDE5

Q35241051-2082081B-B0C7-4F10-8993-8B9A4BBA08AF

Q35241051-23CA1A55-D033-4432-9172-BE41C9FAE265

Q35241051-346605B8-C4C6-48E9-A447-13FD46208603

Q35241051-3D4D14B7-1E59-46DA-A300-E6CD9E05117E

Q35241051-3E1C6ACB-DBF7-42CB-A380-BEF128A9CE2B

P2888

Q35241051-887694F7-4144-4E99-ABA2-EFCEEA086F0A

P304

Q35241051-59B8BDBF-805C-4273-A91F-75BF2F0A4A91

P31

Q35241051-C00190E0-EE69-4186-B79E-5252EEA24BA1

P356

Q35241051-F8B8680A-DDC5-4E13-A40B-2FC15B123EDE

P478

Q35241051-05EE3575-8BA2-49CC-95FF-82EA838B1404

P577

Q35241051-1D3A5AD6-501E-4A3E-AC6D-2B485F402075

P5875

Q35241051-DA832CA3-3FF8-4318-9F79-79E010712B86

P6179

Q35241051-76703B29-3BAD-4A33-B52D-A5E2E3309A98

P698

Q35241051-324AD622-B121-4612-9A26-735E3C468C20

P921

Q35241051-48152973-B333-4C8B-BEB1-FB426001DD80

P932

Q35241051-7BC7CDA0-E307-4FCA-AC06-3D687FBADFED

P356

1756-9966-30-84

P1433

Journal of Experimental & Clinical Cancer Research

P1476

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

@en

P2093

Hanna Ronkainen

http://www.w3.org/2001/XMLSchema#string

Katri S Selander

http://www.w3.org/2001/XMLSchema#string

Katri S Vuopala

http://www.w3.org/2001/XMLSchema#string

Markku H Vaarala

http://www.w3.org/2001/XMLSchema#string

Pasi Hirvikoski

http://www.w3.org/2001/XMLSchema#string

Saila Kauppila

http://www.w3.org/2001/XMLSchema#string

Timo K Paavonen

http://www.w3.org/2001/XMLSchema#string

P2860

A novel Toll-like receptor that recognizes vesicular stomatitis virus

Human lung cancer cells express functionally active Toll-like receptor 9

Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?

Changes in intestinal Toll-like receptors and cytokines precede histological injury in a rat model of necrotizing enterocolitis

Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia

TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients.

Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis

Toll-like receptor 9 enhances nephritogenic immunity and glomerular leukocyte recruitment, exacerbating experimental crescentic glomerulonephritis.

The changing natural history of renal cell carcinoma.

Prognostic factors and molecular markers for renal cell carcinoma.

P2888

1756-9966-30-84

P304

84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-9966-30-84

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51654126

http://www.w3.org/2001/XMLSchema#string

P6179

1003335297

http://www.w3.org/2001/XMLSchema#string

P698

21929816

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

3182949

http://www.w3.org/2001/XMLSchema#string